AMP-activated Protein Kinase Is Required for the Lipid-lowering Effect of Metformin in Insulin-resistant Human HepG2 Cells

Mengwei Zang(The University of Texas at San Antonio Health Science Center), Richard A. Cohen(Cardiovascular Institute of the South)
Journal of Biological Chemistry
September 15, 2004
Cited by 454


Related Papers